RedRobot<p>Cambridge-based Maxion Therapeutics raises €68.9 million in Series A funding led by General Catalyst to advance its KnotBody pipeline targeting ion channel and GPCR-driven diseases.Maxion Therapeutics, a Cambridge-based biotech firm, has raised €68.9 million in a Series A funding round led by General Catalyst. <a href="https://mastodon.social/tags/biotech" class="mention hashtag" rel="tag">#<span>biotech</span></a> <a href="https://mastodon.social/tags/drugdevelopment" class="mention hashtag" rel="tag">#<span>drugdevelopment</span></a> <a href="https://mastodon.social/tags/funding" class="mention hashtag" rel="tag">#<span>funding</span></a> <a href="https://mastodon.social/tags/GPCR" class="mention hashtag" rel="tag">#<span>GPCR</span></a> <a href="https://mastodon.social/tags/ionchannels" class="mention hashtag" rel="tag">#<span>ionchannels</span></a> </p><p><a href="https://redrobot.online/2025/03/maxion-therapeutics-secures-e68-million-in-series-a-funding-for-antibody-based-drug-development/" target="_blank" rel="nofollow noopener" translate="no"><span class="invisible">https://</span><span class="ellipsis">redrobot.online/2025/03/maxion</span><span class="invisible">-therapeutics-secures-e68-million-in-series-a-funding-for-antibody-based-drug-development/</span></a></p>